Publication | Open Access
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
70
Citations
16
References
2016
Year
Neuro-oncologyHealth SciencesMedicineMetronomic TherapyHigh-grade GliomasCancer TreatmentRecurrent GlioblastomaRadiation OncologyOncologyGliomaRadiologyDose-dense Temozolomide
| Year | Citations | |
|---|---|---|
Page 1
Page 1